These days, the frontier AI labs are all racing to build self-improving models. Some believe it’s the surest route to ...

At the moment, many of the big AI systems used in drug discovery are closed-source, meaning they are proprietary and carry an ...

What if the same Bitcoin signature could authorize spending from multiple different UTXOs? BIP 118's ANYPREVOUT does exactly ...

Self-improving models are reshaping the AI race as OpenAI, Anthropic, Google and others pursue superintelligence.

Vitalik Buterin has published an updated long-term roadmap for Ethereum, calling the multi-year effort “Lean Ethereum” as the network’s biggest redesign since the Merge. He posted it to X on July 4, ...

AI is becoming more capable, but its value still depends on the data, questions and decisions behind it. Where is it ...

The rise of AI has brought an avalanche of new terms and slang. Here is a glossary with definitions of some of the most ...

Model collapse AI training data risk grows as Meta’s Brand Memory ad tools flood the open web with synthetic content, ...

New artificial intelligence models are not only able to identify software vulnerabilities but can also instantly provide the appropriate attack tools ...

Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...